Location: Strasbourg (Hybrid) Workload: Ideally full-time but open for applicants who are only available part-time. Compensation: competitive salary + milestone-based equity (after fundraising)
Early-stage venture developing an innovative regenerative therapy for orthopaedic applications. The technology combines a proprietary medical device with a stem cell-based hydrogel. With regulatory approvals already in place for the product components, we are focused on building a compelling business case and securing funding ahead of clinical trials.
We are seeking a commercially-driven Chief Operating Officer (COO) to lead the refinement of our business strategy and drive fundraising efforts. The COO will be instrumental in translating scientific progress into a credible commercial opportunity. This role is initially part-time, with the potential to evolve as the company grows. This is not a guaranteed pathway to CEO, though it could become one depending on future needs.
Fundraising Leadership:
Business Planning:
Execution Support:
Proven experience raising funds for early-stage healthcare ventures
Ability to translate complex science into a compelling investor story
Strong commercial mindset and strategic thinking
Comfortable working hands-on with lean teams
Fluent in English and French
Willingness to be present regularly in Strasbourg
Background in medtech, orthopedics, or adjacent sectors
Familiarity with early-stage clinical or product development processes
This start-up is being built in collaboration with NLC Health Ventures, Europe's leading healthtech venture builder. With over 100 ventures created to date, NLC identifies breakthrough innovations, builds expert teams around them, and supports each venture from lab to market. Through hands-on operational guidance, fundraising support, and access to dedicated capital, NLC helps founders turn scientific breakthroughs into investable, scalable companies.